Susanne Herold Selected Research

Fibroblast Growth Factor 10

1/2022	FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells.
1/2017	Origin and characterization of alpha smooth muscle actin-positive cells during murine lung development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Herold Research Topics

Disease

27	Infections 01/2022 - 08/2006
14	Pneumonia (Pneumonitis) 01/2022 - 11/2007
13	Hyperoxia 01/2022 - 04/2014
13	Bronchopulmonary Dysplasia 01/2022 - 02/2014
12	Lung Injury 11/2017 - 05/2011
11	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 10/2012
10	Acute Lung Injury 11/2017 - 03/2009
9	Human Influenza (Influenza) 01/2022 - 08/2006
7	Edema (Dropsy) 12/2021 - 01/2016
6	Neoplasms (Cancer) 01/2022 - 03/2009
6	Inflammation (Inflammations) 01/2019 - 05/2011
5	Lung Diseases (Lung Disease) 01/2022 - 02/2014
4	Critical Illness (Critically Ill) 01/2022 - 04/2014
4	COVID-19 01/2022 - 01/2020
4	Fibrosis (Cirrhosis) 01/2022 - 02/2014
4	Hypercapnia 12/2021 - 01/2017
4	Virus Diseases (Viral Diseases) 01/2017 - 03/2016
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2020
3	Premature Birth (Birth, Premature) 01/2021 - 01/2019
2	Asthma (Bronchial Asthma) 01/2022 - 02/2014
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2017
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 11/2017
2	Hypertension (High Blood Pressure) 12/2020 - 08/2017
2	Genomic Instability 01/2016 - 11/2015
2	Hypoxia (Hypoxemia) 07/2014 - 12/2010
1	Severe Acute Respiratory Syndrome 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	IgG Deficiency 01/2021
1	Alopecia (Baldness) 12/2020
1	Lung agenesis 01/2020
1	Ventilator-Induced Lung Injury 01/2020

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
8	Adenosine Triphosphatases (ATPase)IBA 12/2021 - 01/2016
6	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2012
6	LigandsIBA 01/2020 - 11/2007
5	CytokinesIBA 01/2022 - 03/2009
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2014
4	EnzymesIBA 12/2021 - 07/2014
4	Oxygen (Dioxygen)IBA 01/2021 - 12/2010
4	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2020 - 05/2015
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2016 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
3	CollagenIBA 01/2018 - 07/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 06/2017
3	TNF-Related Apoptosis-Inducing LigandIBA 01/2017 - 12/2008
2	AntibodiesIBA 01/2022 - 12/2008
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 02/2014
2	Fibroblast Growth Factor 10IBA 01/2022 - 01/2017
2	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 12/2020 - 02/2014
2	Carbon DioxideIBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2010
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2019
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2018 - 07/2014
2	Ion Channels (Ion Channel)IBA 11/2017 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 08/2017 - 07/2014
2	InterferonsIBA 01/2017 - 01/2017
2	Epithelial Sodium ChannelsIBA 01/2017 - 01/2014
2	LipopolysaccharidesIBA 01/2016 - 11/2007
2	delta-hydroxylysylnorleucineIBA 06/2015 - 07/2014
2	AminopropionitrileIBA 06/2015 - 07/2014
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 06/2015 - 07/2014
2	EmulsionsIBA 05/2015 - 04/2014
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2015 - 04/2014
2	LipidsIBA 05/2015 - 04/2014
2	Fish OilsIBA 05/2015 - 04/2014
2	Interleukin-10 (Interleukin 10)IBA 02/2015 - 04/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 12/2008
1	AutoantibodiesIBA 01/2022
1	AutoantigensIBA 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 12/2021
1	Inositol (Myoinositol)IBA 12/2021
1	valspodar (PSC 833)IBA 03/2021
1	UbiquitinIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	HeterochromatinIBA 01/2021
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2020
1	Minoxidil (Rogaine)FDA LinkGeneric 12/2020
1	Nicotine FDA Link 10/2020
1	SmokeIBA 10/2020
1	Cell Adhesion MoleculesIBA 02/2020
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 02/2020
1	Adenosine Triphosphate (ATP)IBA 02/2020
1	Membrane Transport Proteins (Biological Pump)IBA 02/2020

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2014
2	Parenteral Nutrition 05/2015 - 04/2014
2	Immunomodulation 05/2015 - 04/2014
1	Length of Stay 01/2021